$2.81
+0.12 (+4.46%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-58.40%
1Y
-85.21%
YTD
-85.21%
Open$2.69
Previous Close$2.69
Day High$3.07
Day Low$2.60
52W High$24.09
52W Low$2.55
Volume—
Avg Volume206.9K
Market Cap1.75B
P/E Ratio—
EPS$-1.17
SectorN/A
Technical Indicators
Full analysis →
RSI (14)
72.7
Overbought
Analyst Ratings
Strong Buy
8 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 897.79M | 924.30M | 800.01M |
| Net Income | 130.26M | 123.87M | 128.43M |
| Profit Margin | 14.5% | 13.4% | 16.1% |
| EBITDA | 262.26M | 279.12M | 215.46M |
| Free Cash Flow | 117.43M | 106.34M | 120.15M |
| Rev Growth | +21.7% | -6.1% | -8.9% |
| Debt/Equity | 0.23 | 0.23 | 0.24 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| PICS | Pics Nv | $12.80 | -3.03% | 6.8 | 1.56B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.20% | 75.0 | 644.01M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.28% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | -0.10% | 57.7 | 593.79M |
| BCSS | Bain Capital Gss Inv- A | $10.22 | +0.00% | 71.9 | 596.26M |